Compugen (CGEN) Treasury Shares (2024 - 2025)
Compugen recorded quarterly Treasury Shares of $567400.0 in Q4 2025, up 78.79% quarter-over-quarter from $317350.0 in Q4 2024, and up 78.79% year-over-year from $317350.0 in Q4 2024.
Compugen's Treasury Shares history runs 2 years deep, the most recent figure standing at $567400.0 for Q4 2025.
- In Q4 2025, Treasury Shares rose 78.79% year-over-year to $567400.0; the TTM figure through Dec 2025 stood at $567400.0 (up 78.79% YoY), while the FY2025 annual figure was $567400.0, up 78.79% from the prior year.
- Treasury Shares came in at $567400.0 for Q4 2025 at Compugen, up from $317350.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $567400.0 in Q4 2025 to a low of $317350.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 567,400.00 |
| Dec 31, 2025 | 567,400.00 |
| Dec 31, 2024 | 317,350.00 |
| Dec 31, 2024 | 317,350.00 |